Clinical Trials
3 trialsNCT00086528 2022-05-13
Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors
Kadmon Corporation, LLC
Phase 1 Completed
NCT00336765 2022-05-13
Study of XL647 Administered Orally Daily to Patients With Solid Tumors
Kadmon Corporation, LLC
Phase 1 Completed
NCT00704392 2015-08-20
Safety Study of XL647 and XL147 Administered in Combination Daily in Adults With Solid Tumors
Exelixis
Phase 1 Withdrawn